Skip to main content

Table 1 Clinicopathological characteristics of 28 patients with estrogen receptor-positive invasive ductal carcinoma

From: Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer

Characteristic

Recurrence group N (%)

Non-recurrence group N (%)

p value

Age (range)

41.0 (24–62)

43.1 (29–65)

0.576

T stage

   

   T1

2 (22.2)

2 (10.5)

 

   T2

7 (77.8)

17 (89.5)

0.409

Lymph node metastasis

   

   Negative

2 (22.2)

6 (31.6)

 

   Positive

7 (77.8)

13 (68.4)

0.609

Histological grade

   

   1–2

4 (44.4)

11 (57.9)

 

   3

5 (55.6)

8 (42.1)

0.505

Nuclear grade

   

   1–2

4 (44.4)

7 (36.8)

 

   3

5 (55.6)

12 (63.2)

0.700

PR

   

   Positive

6 (66.7)

14 (73.7)

 

   Negative

3 (33.3)

5 (26.3)

0.701